Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Valves01:16

Heart Valves

14.7K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
14.7K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.3K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

913
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
913
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2011
Same author

Evolution of sensory complexity recorded in a myxobacterial genome.

Proceedings of the National Academy of Sciences of the United States of America·2006
Same author

Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.

International journal of immunopharmacology·2003
Same author

Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.

International immunopharmacology·2002
Same author

Midterm survival of stented versus stentless valves: does concomitant coronary artery bypass grafting impact survival?

Seminars in thoracic and cardiovascular surgery·2002
Same author

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58.

Science (New York, N.Y.)·2001

相关实验视频

Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

早期使用无支架或支架门的经验.

G Cohen1, G T Christakis, K J Buth

  • 1Division of Cardiovascular Surgery, Sunnybrook Health Sciences Centre and The Toronto Hospital, University of Toronto, Ontario, Canada.

Circulation
|December 31, 1997
PubMed
概括

多伦多无支架的猪 (SPV) 显示,与支架 (STD) 相比,在主动脉更换后心室功能得到改善. 然而,在本研究中,在SPV和STD组之间没有观察到显著的血液动力学差异.

更多相关视频

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

相关实验视频

Last Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

科学领域:

  • 心血管外科心血管外科
  • 生物材料科学 生物材料科学
  • 医疗器械 医疗器械

背景情况:

  • 多伦多无支架的猪 (SPV) 开发的目的是通过增加流量面积,与传统的支架 (STD) 相比,提高主动脉置换 (AVR) 中的血液动力学.
  • 评估血液动力学性能对于优化AVR后的结果至关重要.

研究的目的:

  • 为了前性地比较多伦多无支架猪 (SPV) 和隔离性大动脉置换后支架 (STD) 之间的血液动力学性能和心室重塑.
  • 评估与SPV植入相关的腹腔力学潜在的功能改善.

主要方法:

  • 一项前性研究涉及59名接受隔离AVR (+/-冠状动脉旁路移植) 的患者.
  • 患者接受了支架门 (STD,n=23) 或多伦多无支架的猪门 (SPV,n=36).
  • 术前和3至6个月后的心声回声被用于评估血液动力学参数和左心室质量指数.

主要成果:

  • 平均而言,SPV植入物是较大的 (26.6毫米对24.0毫米,P=0.0002).
  • 手术后的有效孔径面积显著增加 (P=0.0001),特别是在SPV组 (1.9cm2对1.5cm2,P=0.01).
  • 通过分数缩短和周长缩短的速度来衡量心室功能,在SPV患者中显著改善 (分别P=0.0004和P=0.0001).

结论:

  • 虽然SPV植入与心室功能的改善有关,但SPV和STD组之间没有发现显著的血液动力学差异.
  • 非随机设计可能会引入选择偏差,可能会影响观察到的结果.
  • 通过前性随机试验进行进一步的调查是有必要的,以确定SPV的血液动力学优势.